These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 34373739)
1. Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities. Yan T; Xiao R; Wang N; Shang R; Lin G Theranostics; 2021; 11(17):8234-8253. PubMed ID: 34373739 [TBL] [Abstract][Full Text] [Related]
2. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives. Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
4. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents. Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711 [TBL] [Abstract][Full Text] [Related]
5. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection. Huizinga GP; Singer BH; Singer K Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654 [TBL] [Abstract][Full Text] [Related]
6. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm. Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876 [TBL] [Abstract][Full Text] [Related]
7. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996 [TBL] [Abstract][Full Text] [Related]
8. Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review. Liu BM; Hill HR J Interferon Cytokine Res; 2020 Dec; 40(12):549-554. PubMed ID: 33337932 [TBL] [Abstract][Full Text] [Related]
12. Severe COVID-19: what have we learned with the immunopathogenesis? Bordallo B; Bellas M; Cortez AF; Vieira M; Pinheiro M Adv Rheumatol; 2020 Sep; 60(1):50. PubMed ID: 32962761 [TBL] [Abstract][Full Text] [Related]
13. The Centrality of Obesity in the Course of Severe COVID-19. Liu D; Zhang T; Wang Y; Xia L Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917 [TBL] [Abstract][Full Text] [Related]
14. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D. Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features? Busetto GM; Porreca A; Del Giudice F; Maggi M; D'Agostino D; Romagnoli D; Musi G; Lucarelli G; Palmer K; Colonna di Paliano A; Muto M; Hurle R; Terracciano D; de Cobelli O; Sciarra A; De Berardinis E; Ferro M Urol Int; 2020; 104(7-8):510-522. PubMed ID: 32516772 [TBL] [Abstract][Full Text] [Related]
16. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Korakas E; Ikonomidis I; Kousathana F; Balampanis K; Kountouri A; Raptis A; Palaiodimou L; Kokkinos A; Lambadiari V Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E105-E109. PubMed ID: 32459524 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention. Sharma JR; Yadav UCS Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701 [TBL] [Abstract][Full Text] [Related]